Artelo Biosciences, Inc. (ARTL) SEC Filings https://ir.artelobio.com/sec-filings/all-sec-filings/rss Artelo Biosciences, Inc. (ARTL) - All SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/artelobio/files/theme/images/logo-sm.png Artelo Biosciences, Inc. Logo Equisolve Investor Relations Suite <![CDATA[EFFECT - Notice of Effectiveness]]> https://ir.artelobio.com/sec-filings/all-sec-filings/content/9999999995-26-001202/9999999995-26-001202.pdf Thu, 16 Apr 26 06:04:39 -0400 https://ir.artelobio.com/sec-filings/all-sec-filings/content/9999999995-26-001202/9999999995-26-001202.pdf <![CDATA[424B3 - Prospectus [Rule 424(b)(3)]]]> https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001640334-26-000761/0001640334-26-000761.pdf Thu, 16 Apr 26 08:00:43 -0400 https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001640334-26-000761/0001640334-26-000761.pdf <![CDATA[S-1 - General form for registration of securities under the Securities Act of 1933]]> https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001640334-26-000670/0001640334-26-000670.pdf Tue, 07 Apr 26 16:20:01 -0400 https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001640334-26-000670/0001640334-26-000670.pdf <![CDATA[8-K - Current report]]> https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001640334-26-000662/0001640334-26-000662.pdf Tue, 07 Apr 26 08:00:46 -0400 https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001640334-26-000662/0001640334-26-000662.pdf <![CDATA[D - Notice of Exempt Offering of Securities]]> https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001621221-26-000005/0001621221-26-000005.pdf Mon, 06 Apr 26 12:57:59 -0400 https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001621221-26-000005/0001621221-26-000005.pdf <![CDATA[SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors]]> https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001213900-26-039993/0001213900-26-039993.pdf Tue, 14 Apr 26 13:01:37 -0400 https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001213900-26-039993/0001213900-26-039993.pdf <![CDATA[EFFECT - Notice of Effectiveness]]> https://ir.artelobio.com/sec-filings/all-sec-filings/content/9999999995-26-001002/9999999995-26-001002.pdf Tue, 31 Mar 26 06:16:02 -0400 https://ir.artelobio.com/sec-filings/all-sec-filings/content/9999999995-26-001002/9999999995-26-001002.pdf <![CDATA[8-K - Current report]]> https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001640334-26-000574/0001640334-26-000574.pdf Mon, 30 Mar 26 17:45:06 -0400 https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001640334-26-000574/0001640334-26-000574.pdf <![CDATA[D - Notice of Exempt Offering of Securities]]> https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001621221-26-000004/0001621221-26-000004.pdf Fri, 27 Mar 26 17:01:49 -0400 https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001621221-26-000004/0001621221-26-000004.pdf <![CDATA[D - Notice of Exempt Offering of Securities]]> https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001621221-26-000003/0001621221-26-000003.pdf Fri, 27 Mar 26 17:01:19 -0400 https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001621221-26-000003/0001621221-26-000003.pdf